AGL 40.00 Decreased By ▼ -0.16 (-0.4%)
AIRLINK 129.53 Decreased By ▼ -2.20 (-1.67%)
BOP 6.68 Decreased By ▼ -0.01 (-0.15%)
CNERGY 4.63 Increased By ▲ 0.16 (3.58%)
DCL 8.94 Increased By ▲ 0.12 (1.36%)
DFML 41.69 Increased By ▲ 1.08 (2.66%)
DGKC 83.77 Decreased By ▼ -0.31 (-0.37%)
FCCL 32.77 Increased By ▲ 0.43 (1.33%)
FFBL 75.47 Increased By ▲ 6.86 (10%)
FFL 11.47 Increased By ▲ 0.12 (1.06%)
HUBC 110.55 Decreased By ▼ -1.21 (-1.08%)
HUMNL 14.56 Increased By ▲ 0.25 (1.75%)
KEL 5.39 Increased By ▲ 0.17 (3.26%)
KOSM 8.40 Decreased By ▼ -0.58 (-6.46%)
MLCF 39.79 Increased By ▲ 0.36 (0.91%)
NBP 60.29 No Change ▼ 0.00 (0%)
OGDC 199.66 Increased By ▲ 4.72 (2.42%)
PAEL 26.65 Decreased By ▼ -0.04 (-0.15%)
PIBTL 7.66 Increased By ▲ 0.18 (2.41%)
PPL 157.92 Increased By ▲ 2.15 (1.38%)
PRL 26.73 Increased By ▲ 0.05 (0.19%)
PTC 18.46 Increased By ▲ 0.16 (0.87%)
SEARL 82.44 Decreased By ▼ -0.58 (-0.7%)
TELE 8.31 Increased By ▲ 0.08 (0.97%)
TOMCL 34.51 Decreased By ▼ -0.04 (-0.12%)
TPLP 9.06 Increased By ▲ 0.25 (2.84%)
TREET 17.47 Increased By ▲ 0.77 (4.61%)
TRG 61.32 Decreased By ▼ -1.13 (-1.81%)
UNITY 27.43 Decreased By ▼ -0.01 (-0.04%)
WTL 1.38 Increased By ▲ 0.10 (7.81%)
BR100 10,407 Increased By 220 (2.16%)
BR30 31,713 Increased By 377.1 (1.2%)
KSE100 97,328 Increased By 1781.9 (1.86%)
KSE30 30,192 Increased By 614.4 (2.08%)

KARACHI: A multi-million rupee project was launched to promote research in medical and health science, where young researchers and healthcare professionals in the field of orthopaedics from across the country would be offered financial assistance for conducting research in their field to find local solutions of problems facing people.

In order to facilitate research in the field of orthopaedics, a Memorandum of Understanding (MoU) was signed between Pakistan Orthopaedic Association and Pharmevo Research Forum to select four top proposals for research and awarded the research grant at 36th Pak OrthoCon 2023 which would be held from November 2 to 5 in Karachi.

Dr Masood Jawaid from Pharmevo Research Forum while Prof Asadullah Makhdoom and Prof Azeem Akhund of Pakistan Orthopaedic Association, signed the MoU on behalf of their organisations.

Designed and launched by Pharmevo Research Forum, the project would engage different researchers and healthcare professionals from Pakistan who would be awarded one million research grants by the research body for the their endeavour that would lead to identify the areas which needed immediate government attention, policymaking, healthcare solutions of healthcare modification and innovative ideas of providing best, each and low cost treatment facilities to the people of Pakistan.

Addressing the MoU signing ceremony, they regretted that the authorities which were expected and supposed to give go-ahead for the clinical trials and research in the field of medical, had actually emerged as key hurdle in approving research projects while lacking enough qualified people to timely such decisions.

They were of the view that the health fraternity in Pakistan didn’t enjoy exact data and trustworthy numbers which were crucial for research based initiative in the field of health sciences.

Speaking on the occasion, Dr Masood Jawaid said the Research Startup Challenge offers a unique platform for young orthopaedic professionals to present their research proposals and compete for the opportunity to secure research grants to advance their projects.

“With this initiative, our aim is to nurture a culture of research and innovation within the Orthopaedics community in Pakistan”, he added.

The primary goal is to encourage and facilitate research activities among young orthopaedic professionals, providing them with a platform to showcase their innovative research ideas and contribute to the advancement of orthopaedics in Pakistan, he said.

The financial support will empower young researchers to conduct in-depth studies, gather data, gain recognition and exposure, and make significant contributions to the orthopaedic community, Dr Jawaid mentioned.

Copyright Business Recorder, 2023

Comments

Comments are closed.